T1	Participants 170 233	67 patients with systemic breast cancer treated by chemotherapy
T2	Participants 606 631	truly responsive patients
T3	Participants 680 733	Twenty-six responding (biochemical/clinical) patients
T4	Participants 1247 1291	true responders for maintenance chemotherapy
